1995
DOI: 10.1148/radiology.197.2.7480704
|View full text |Cite
|
Sign up to set email alerts
|

Cholangiocarcinoma: clinical significance of tumor location along the extrahepatic bile duct.

Abstract: Patients with proximal cancer should undergo primary RT, and expectations should be limited. Patients with distal cancer should undergo resection, and RT may not be needed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
21
0
3

Year Published

1999
1999
2016
2016

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 38 publications
(24 citation statements)
references
References 0 publications
0
21
0
3
Order By: Relevance
“…Polypoid cholangiocarcinoma is infrequently found in both the intra-and extrahepatic ducts. Histologically, this tumor is mostly of the papillary adenocarcinoma type, which shows intraluminal growth (2,56,63). This type of cholangiocarcinoma has a better prognosis than other types of cholangiocarcinoma.…”
Section: Cholangiocarcinomamentioning
confidence: 99%
“…Polypoid cholangiocarcinoma is infrequently found in both the intra-and extrahepatic ducts. Histologically, this tumor is mostly of the papillary adenocarcinoma type, which shows intraluminal growth (2,56,63). This type of cholangiocarcinoma has a better prognosis than other types of cholangiocarcinoma.…”
Section: Cholangiocarcinomamentioning
confidence: 99%
“…2 Therefore, radiation therapy has been recommended as an adjuvant therapy. 10 Many reports suggest that postoperative radiation therapy improves the outcome of patients with unresected, positive microscopic margins; [11][12][13][14][15][16][17] however, the patients in these reports who received radiation therapy were compared with patients who had unresectable tumors, poor performance status, or metastatic disease. Therefore, it is important to establish the benefits of postoperative radiotherapy in a well-designed objective study.…”
Section: Introductionmentioning
confidence: 99%
“…However, a role for such adjuvant therapy has not been defined for patients with distal bile duct cancer, again because of the small experience with these patients. Although one previous study [21]claimed no benefit of adjuvant therapy compared to resection alone, this lack of benefit may have been related to a more advanced stage of disease and the presence of residual disease in that study. No firm conclusions can be drawn from our study since only 6 of the 15 patients were treated with adjuvant chemoradiation.…”
Section: Discussionmentioning
confidence: 68%